Home
Conditions
Nasopharyngeal Carcinoma

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

363 public trials 136 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Active, Not Recruiting

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

NCT07248696

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Active, Not Recruiting

Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC

NCT07248670

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Active, Not Recruiting

Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China

NCT07088861

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

NCT04384627

Conditions: Carcinoma, Head and Neck Neoplasms, Induction Chemotherapy, +13 more
Locations: First People's Hospital of Foshan, Foshan Foshan, China

People's Hospital of Zhongshan City Zhongshan, China

View Trial Details

Active, Not Recruiting

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

NCT04907370

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

First People's Hospital of Foshan Foshan, Guangdong, China

Panyu central hospital Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.

NCT07011329

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +38 more
Locations: Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

NCT04456322

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT04974398

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: City of Hope Duarte, California, United States

Winship Cancer Institute/Emory University Atlanta, Georgia, United States

University of Michigan Ann Arbor, Michigan, United States

Icahn School of Medicine at Mount Sinai New York, United States

View all 56 locations

View Trial Details

Active, Not Recruiting

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

NCT04517214

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Xiaomin Ou Shanghai, China

View Trial Details

Active, Not Recruiting

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

NCT05304468

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China

View Trial Details

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma trial results

Related conditions